Sermorelin reliably does the biochemical thing it is supposed to do: IGF-1 rises within 2 weeks in controlled study. Whether that converts into the outcomes people want is a separate question with a weaker answer, and conflating the two is why expectations and results diverge so often.
Does sermorelin work is three questions wearing one coat. Does it raise IGF-1? Yes, reliably, and that is well documented. Does raising IGF-1 produce the body composition and performance changes people hope for? Partly, slowly, and less than the marketing suggests. Does it work for you specifically? That depends on whether your GH axis was actually low to begin with, which most people never check.
- IGF-1 rises within 2 weeks of correct nightly dosing in controlled study [1]
- Lean body mass increased in men over 16 weeks; fat mass did not change significantly [1]
- Visceral fat reduction in GHRH-analog data required roughly 6 months [2]
- Growth hormone raised lean mass in athletes without improving strength [3]
- The most common reason it appears not to work is dosing timing, not the drug
Does It Work Biochemically? Yes
This part is not in dispute. In a randomized placebo-controlled study of [[Nle27]GHRH(1-29)NH2, a norleucine-substituted analog of the fragment sermorelin is built on, given at 10 mcg/kg nightly for 16 weeks to adults aged 55 to 71](https://pubmed.ncbi.nlm.nih.gov/9141536/) [1], IGF-1 rose within 2 weeks and stayed elevated, and nocturnal GH increased in both men and women.
The mechanism behaves as described: sermorelin binds pituitary GHRH receptors, GH is released, and IGF-1 follows [4]. If your question is whether the compound does something measurable in the body, the answer is yes, and you can verify it in your own labs at 90 days.
Does It Work Clinically? Partly
Here the honest answers get more qualified. The same 16-week trial found increased lean body mass in men and increased skin thickness in both sexes, but no significant change in fat mass [1] across the full period.
| Outcome | Does it work? | Evidence |
|---|---|---|
| Raise IGF-1 | Yes, within 2 weeks | [Controlled trial](https://pubmed.ncbi.nlm.nih.gov/9141536/) [1] |
| Improve sleep depth | Commonly reported at 2 to 4 weeks | Consistent with GH release in [slow-wave sleep](https://pubmed.ncbi.nlm.nih.gov/5675428/) [5] |
| Increase lean mass | In men, over 16 weeks | Trial data; not demonstrated in women [1] |
| Reduce visceral fat | Over roughly 6 months | [GHRH-analog pooled data](https://pmc.ncbi.nlm.nih.gov/articles/PMC4324360/) [2] |
| Reduce total fat mass | Not within 16 weeks | No significant change [1] |
| Increase strength | Not demonstrated | [GH raised lean mass without strength gain](https://pubmed.ncbi.nlm.nih.gov/18347346/) [3] |
The strength finding deserves emphasis because it is the most commonly overstated. A systematic review of growth hormone in athletes concluded that claims growth hormone enhances physical performance are not supported by the scientific literature [3], with lean body mass rising about 2.1 kg while strength and exercise capacity did not improve. Gaining lean mass and gaining usable strength are different outcomes.
Does It Work for You? That Depends on Your Baseline
Sermorelin restores a declining axis toward normal. It is not a way to push a normal axis higher, and somatostatin feedback actively prevents that [4]. So the largest single predictor of whether it does anything noticeable is whether your IGF-1 was genuinely low or low-normal for your age before you started.
A 45-year-old with mid-normal IGF-1 and good sleep has little headroom to gain. Someone with documented low IGF-1, poor slow-wave sleep, and rising visceral fat has considerably more. Without a baseline draw, neither knows which they are, which is why prescribing without labs makes the question unanswerable by design.
When It Does Not Work, and Why
Most reports of failure trace to a handful of causes, and only one of them is the medication.
- Wrong timing. Dosing outside bedtime, or within 2 hours of eating, blunts the GH pulse through somatostatin feedback
- Too short a trial. Judging at 4 to 12 weeks, when the 16-week study itself showed no fat mass change [1]
- No baseline. A real IGF-1 response goes unnoticed because there is nothing to compare against
- Untreated hypothyroidism, which suppresses the GH response independently
- Normal starting IGF-1, leaving little room for restoration
- Product quality, since compounded preparations are not FDA-verified for potency before marketing
If your 90-day IGF-1 rose meaningfully and you still feel unchanged, the protocol is working and the timeline is simply longer than you expected. If IGF-1 did not move at all, something upstream of the dose is wrong. Those two situations feel identical from the inside and call for opposite responses.
How to Answer the Question for Yourself
- Draw a baseline IGF-1 before the first dose, interpreted against the age-adjusted range
- Dose at bedtime, at least 2 hours after eating, every night
- Retest IGF-1 at 90 days
- Measure waist circumference under identical conditions rather than tracking scale weight
- Give it 6 months before reaching a verdict
Frequently Asked Questions
Does sermorelin actually work?
For raising IGF-1, yes and reliably: controlled study shows IGF-1 rising within 2 weeks of correct nightly dosing and staying elevated [1]. For clinical outcomes the answer is more qualified. Lean body mass increased in men over 16 weeks while fat mass did not change significantly [1], and visceral fat reduction in GHRH-analog data took roughly 6 months [2].
Does sermorelin work for weight loss?
Not as a weight loss drug. Fat mass did not change significantly across 16 weeks in the controlled trial [1], and GHRH-analog studies needed about 6 months to show visceral fat reduction [2]. It acts on visceral and abdominal fat gradually rather than producing rapid loss, and it does not replace a caloric deficit.
Does sermorelin work for building muscle?
Lean body mass increased in men over 16 weeks in the controlled trial, though not in women [1]. Whether that becomes usable strength is a separate matter: a systematic review of growth hormone in athletes found lean mass rose about 2.1 kg without improvement in strength or exercise capacity, concluding that performance-enhancement claims are not supported [3].
Why is sermorelin not working for me?
Check five things before blaming the medication. Are you dosing at bedtime at least 2 hours after eating? Has it been at least 90 days? Did you draw a baseline IGF-1 to compare against? Has thyroid function been confirmed normal? And was your starting IGF-1 actually low, since sermorelin restores a declining axis rather than pushing a normal one higher [4].
How do I know if sermorelin is working?
The 90-day IGF-1 retest against a pre-treatment baseline. That is the only objective measure available, and it separates the two situations that feel identical: a working protocol on a longer timeline than you expected, versus one that never engaged at all. Subjectively, sleep depth is usually the first change, typically at 2 to 4 weeks [5].
Is sermorelin worth it?
That depends on your baseline and your expectations. For someone with documented low or low-normal IGF-1, poor slow-wave sleep, and rising visceral fat, the mechanism addresses a real deficit and the evidence supports measurable change over 6 months. For someone with normal IGF-1 expecting rapid fat loss or strength gains, the evidence does not support that outcome.
References
- Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women Journal of Clinical Endocrinology & Metabolism, 1997. PMID: 9141536. https://pubmed.ncbi.nlm.nih.gov/9141536/
- Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies Growth Hormone & IGF Research, 2015. PMC4324360. https://pmc.ncbi.nlm.nih.gov/articles/PMC4324360/
- Systematic review: the effects of growth hormone on athletic performance Annals of Internal Medicine, 2008. PMID: 18347346. https://pubmed.ncbi.nlm.nih.gov/18347346/
- Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clinical Interventions in Aging, 2006. PMC2699646. https://pmc.ncbi.nlm.nih.gov/articles/PMC2699646/
- Growth hormone secretion during sleep Journal of Clinical Investigation, 1968. PMID: 5675428. https://pubmed.ncbi.nlm.nih.gov/5675428/
